TY - JOUR
T1 - Current trends and controversies in the management of warthin tumor of the parotid gland†
AU - Quer, Miquel
AU - Hernandez-Prera, Juan C.
AU - Silver, Carl E.
AU - Casasayas, Maria
AU - Simo, Ricard
AU - Vander Poorten, Vincent
AU - Guntinas-Lichius, Orlando
AU - Bradley, Patrick J.
AU - Tong-Ng, Wai
AU - Rodrigo, Juan P.
AU - Mäkitie, Antti A.
AU - Rinaldo, Alessandra
AU - Kowalski, Luiz P.
AU - Sanabria, Alvaro
AU - de Bree, Remco
AU - Takes, Robert P.
AU - López, Fernando
AU - Olsen, Kerry D.
AU - Shaha, Ashok R.
AU - Ferlito, Alfio
N1 - Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/8
Y1 - 2021/8
N2 - Purpose: To review the current options in the management of Warthin tumors (WTs) and to propose a working management protocol. Methods: A systematic literature search was conducted using PubMed and ScienceDirect database. A total of 141 publications were selected and have been included in this review. Publications were selected based on relevance, scientific evidence, and actuality. Results: The importance of parotid WTs is increasing due to its rising incidence in many countries, becoming the most frequently encountered benign parotid tumor in certain parts of the world. In the past, all WTs were treated with surgery, but because of their slow growth rate, often minimal clinical symptoms, and the advanced age of many patients, active observation has gradually become more widely used. In order to decide on active surveillance, the diagnosis of WT must be reliable, and clinical, imaging, and cytological data should be concordant. There are four clear indications for upfront surgery: uncertain diagnosis; cosmetic problems; clinical complaints, such as pain, ulceration, or recurrent infection; and the patient’s wish to have the tumor removed. In the remaining cases, surgery can be elective. Active surveillance is often suggested as the first approach, with surgery being considered if the tumor progresses and/or causes clinical complaints. The extent of surgery is another controversial topic, and the current trend is to minimize the resection using partial parotidectomies and extracapsular dissections when possible. Recently, non-surgical options such as microwave ablation, radiofrequency ablation, and ultrasound-guided ethanol sclerotherapy have been proposed for selected cases. Conclusions: The management of WT is gradually shifting from superficial or total parotidectomy to more conservative approaches, with more limited resections, and to active surveillance in an increasing number of patients. Additionally, non-surgical treatments are emerging, but their role needs to be defined in future studies.
AB - Purpose: To review the current options in the management of Warthin tumors (WTs) and to propose a working management protocol. Methods: A systematic literature search was conducted using PubMed and ScienceDirect database. A total of 141 publications were selected and have been included in this review. Publications were selected based on relevance, scientific evidence, and actuality. Results: The importance of parotid WTs is increasing due to its rising incidence in many countries, becoming the most frequently encountered benign parotid tumor in certain parts of the world. In the past, all WTs were treated with surgery, but because of their slow growth rate, often minimal clinical symptoms, and the advanced age of many patients, active observation has gradually become more widely used. In order to decide on active surveillance, the diagnosis of WT must be reliable, and clinical, imaging, and cytological data should be concordant. There are four clear indications for upfront surgery: uncertain diagnosis; cosmetic problems; clinical complaints, such as pain, ulceration, or recurrent infection; and the patient’s wish to have the tumor removed. In the remaining cases, surgery can be elective. Active surveillance is often suggested as the first approach, with surgery being considered if the tumor progresses and/or causes clinical complaints. The extent of surgery is another controversial topic, and the current trend is to minimize the resection using partial parotidectomies and extracapsular dissections when possible. Recently, non-surgical options such as microwave ablation, radiofrequency ablation, and ultrasound-guided ethanol sclerotherapy have been proposed for selected cases. Conclusions: The management of WT is gradually shifting from superficial or total parotidectomy to more conservative approaches, with more limited resections, and to active surveillance in an increasing number of patients. Additionally, non-surgical treatments are emerging, but their role needs to be defined in future studies.
KW - Adenolymphoma
KW - Cystadenolymphoma
KW - Lymphomatous adenoma
KW - Papillary cystadenoma lymphomatosum
KW - Parotid tumor
KW - Warthin tumor
KW - parotid tumor
KW - adenolymphoma
KW - cystadenolymphoma
KW - lymphomatous adenoma
KW - papillary cystadenoma lymphomatosum
UR - http://www.scopus.com/inward/record.url?scp=85112745620&partnerID=8YFLogxK
U2 - 10.3390/diagnostics11081467
DO - 10.3390/diagnostics11081467
M3 - Review article
C2 - 34441400
AN - SCOPUS:85112745620
SN - 2075-4418
VL - 11
JO - Diagnostics
JF - Diagnostics
IS - 8
M1 - 1467
ER -